Stock Analiz

Lyell Immunopharma, Inc. (LYEL) stock forecast and price target

Price $14.30 · data as of November 13, 2026

12-month price target

Average target$37.62
Upside / downside+163.1%
Analysts8
ConsensusBuy
Low $12.00Average $37.62High $49.00

Gold marker: average target · white marker: today’s price ($14.30)

Analyst ratings

Strong buy 2Buy 5Hold 0Sell 0Strong sell 1

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-6.69—$13860
Next fiscal year
ends December 31, 2027
$-5.91+11.7%$8780
Next quarter
ends December 31, 2026
$-1.57—$6710
Quarter after
ends March 31, 2027
$-1.69—$5000

Consensus of the analysts covering Lyell Immunopharma, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.

Frequently asked questions

What is the Lyell Immunopharma stock price target?

The average 12-month target from 8 analysts is $37.62, 163.1% above the current price of $14.30 Targets range from $12.00 to $49.00.

Is Lyell Immunopharma a buy according to analysts?

The consensus rating is “Buy” (2 strong buy, 5 buy, 1 strong sell). Ratings are opinions, not guarantees; this is not investment advice.

How much is Lyell Immunopharma expected to earn?

Analysts expect EPS of $-6.69 for the fiscal year ending December 31, 2026 and $-5.91 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.